| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/17/1994 | WO1994003611A2 Ptp-d subfamily of protein tyrosine phosphatases |
| 02/17/1994 | WO1994003605A2 Compositions and methods for detecting human herpesvirus 6 strain z29 |
| 02/17/1994 | WO1994003604A1 PfEMP3 MALARIA ANTIGEN, ANALOGS, ANTIBODIES AND USES THEREOF |
| 02/17/1994 | WO1994003600A1 Morphogenic protein soluble complex and composition thereof |
| 02/17/1994 | WO1994003595A1 Non-shedding live herpesvirus vaccine |
| 02/17/1994 | WO1994003589A2 Hepatitis a virus vaccine |
| 02/17/1994 | WO1994003493A1 Peptides derived from an immunosuppressive region in the retroviral genome |
| 02/17/1994 | WO1994003490A1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 02/17/1994 | WO1994003487A1 New peptides, antibodies raised against peptides and means for blocking said antibodies, application as medicaments, pharmaceutical compositions and utilization methods |
| 02/17/1994 | WO1994003208A1 Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them |
| 02/17/1994 | WO1994003207A1 Herpesvirus vaccines |
| 02/17/1994 | WO1994003206A1 Tetanus vaccine production |
| 02/17/1994 | WO1994003205A1 Hla binding peptides and their uses |
| 02/17/1994 | WO1994003202A1 Interleukin-4 stimulated t lymphocyte cell death |
| 02/17/1994 | WO1994003196A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | WO1994003191A1 NON-PEPTIDYL MOIETY-CONJUGATED CD4-GAMMA2 AND CD4-IgG2 IMMUNOCONJUGATES, AND USES THEREOF |
| 02/17/1994 | WO1994000586A3 Infectious bovine rhinotracheitis virus mutants and vaccines |
| 02/17/1994 | WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof |
| 02/17/1994 | WO1993025577A3 Active component of parathyroid hypertensive factor |
| 02/17/1994 | WO1993025240A3 Pretargeting methods and compounds |
| 02/17/1994 | WO1993018054A3 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 02/17/1994 | CA2142185A1 Inhibitors of cell proliferation, their preparation and use |
| 02/17/1994 | CA2141960A1 Hla binding peptides and their uses |
| 02/17/1994 | CA2141847A1 Ptp-d subfamily of protein tyrosine phosphatases |
| 02/17/1994 | CA2141678A1 New tumor diagnosing or therapeutical probe |
| 02/17/1994 | CA2141673A1 Non-peptidyl moiety-conjugated cd4-gamma2 and cd4-igg2 immunoconjugates, and uses thereof |
| 02/17/1994 | CA2139592A1 Immunoassay for the detection of collagen or collagen fragments |
| 02/16/1994 | EP0583142A2 Hepatitis A virus vaccine |
| 02/16/1994 | EP0582672A1 Methods to detect and treat diseases caused by bacterial allergens |
| 02/16/1994 | EP0582595A1 Novel antibodies, and methods for their use |
| 02/16/1994 | CN1082053A Synthetic polypeptides |
| 02/15/1994 | US5286852 Antibodies specific towards HIV-1 gp 48 |
| 02/15/1994 | US5286851 For selective binding to doxorubicin(and derivatives) |
| 02/15/1994 | US5286850 Antibody DTPA-type ligand conjugates |
| 02/15/1994 | US5286640 Entero- or rhinoviruses suitable for use as vaccines |
| 02/15/1994 | US5286639 With DNA coding for newcastle disease virus-derived hemagglutinin renuramindase a non-essential genome region |
| 02/15/1994 | US5286484 Bactericides |
| 02/15/1994 | US5286483 50 kilodalton antigen obtained from the intraerythrocytic phase of plasmodium falciparum |
| 02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
| 02/13/1994 | CA2103933A1 Mycobacterium dna fragments, amplification primers, hybridization probes, reactants and a process for the detection of mycobacteria |
| 02/11/1994 | CA2103515A1 Hepatitis a virus vaccine |
| 02/10/1994 | DE4225569A1 Neue Sonde zur Tumordiagnostik oder Tumortherapie New probe for tumor diagnosis and tumor therapy |
| 02/09/1994 | EP0582477A1 Method for diagnosing cancer and pharmaceutical composition |
| 02/09/1994 | EP0582243A2 HCV peptide antigens and a method of testing for the hepatitis C virus (HCV) |
| 02/09/1994 | EP0581906A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs |
| 02/09/1994 | EP0581882A1 Process of screening plasma samples for effective antibody titers against respiratory viruses |
| 02/09/1994 | EP0581836A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
| 02/09/1994 | EP0581803A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 02/09/1994 | EP0366770B1 Liposomes coupled to hormones |
| 02/09/1994 | EP0343227B1 Selective removal of immune complexes |
| 02/09/1994 | CN1081716A Recombiant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
| 02/09/1994 | CN1081715A Stem cell proliferation factor |
| 02/09/1994 | CN1081621A Preparation method of vaccine for pigs trichina disease |
| 02/08/1994 | US5284935 Major histocompatibility complex |
| 02/08/1994 | US5284931 Intercellular adhesion molecules, and their binding ligands |
| 02/08/1994 | US5284830 Stimulating cartilage repair |
| 02/08/1994 | US5284764 Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3 |
| 02/08/1994 | US5284751 Detecting thrombi, clotting disorders |
| 02/08/1994 | US5284652 Reduces the risk of infection to man and other animals; provides cross-immunity |
| 02/08/1994 | US5284644 Functionalized polyamine chelants and rhodium complexes thereof for conjugation to antibodies |
| 02/08/1994 | CA2103533A1 Hcv peptide antigens and method of determining hcv |
| 02/08/1994 | CA1326940C Purification of lfa-3 |
| 02/08/1994 | CA1326819C Pharmaceutical structure |
| 02/08/1994 | CA1326818C Disease control in avian species by embryonal vaccination with a nonreplicating immunogen |
| 02/06/1994 | CA2101868A1 Granulocyte-binding antibody constructs, their preparation and use |
| 02/04/1994 | CA2101357A1 Veterinary method |
| 02/03/1994 | WO1994002633A1 Diagnostic method |
| 02/03/1994 | WO1994002626A1 Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
| 02/03/1994 | WO1994002614A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 02/03/1994 | WO1994002613A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 02/03/1994 | WO1994002612A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 02/03/1994 | WO1994002596A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 02/03/1994 | WO1994002508A2 Polypeptide antigens of mycobacterium bovis |
| 02/03/1994 | WO1994002506A1 Peptide compounds |
| 02/03/1994 | WO1994002450A1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours |
| 02/03/1994 | WO1994002178A1 Targeting of liposomes to the blood-brain barrier |
| 02/03/1994 | WO1994002175A1 Alleviation of symptoms associated with inflammatory disease states |
| 02/03/1994 | WO1994002173A1 Multiple particulate antigen delivery system |
| 02/03/1994 | WO1994002171A1 Prophylactic and therapeutic control of retroviral infections |
| 02/03/1994 | WO1994002169A1 Vaccines against metazoan parasites |
| 02/03/1994 | WO1994002167A1 p53 VACCINE |
| 02/03/1994 | WO1994002162A1 Peptide medicaments for treating disease |
| 02/03/1994 | WO1994002149A1 Convergent combination anti-viral therapy |
| 02/03/1994 | WO1994002105A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | WO1993021321A3 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/03/1994 | DE4225038A1 Herstellung und Verwendung von Antikörpern gegen Kollagen Preparation and use of antibodies against collagen |
| 02/03/1994 | CA2149121A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | CA2141216A1 Targeting of liposomes to the blood-brain barrier |
| 02/03/1994 | CA2140673A1 Vaccines against metazoan parasites |
| 02/03/1994 | CA2140151A1 Peptides that mimic gp120 hiv epitope |
| 02/03/1994 | CA2140033A1 Peptide medicaments for treating disease |
| 02/03/1994 | CA2139517A1 Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
| 02/03/1994 | CA2139410A1 Diagnostic method |
| 02/02/1994 | EP0581353A1 Monoclonal antibodies to HiV-1 gp120, cell lines producing them and corresponding epitope structures |
| 02/02/1994 | EP0581108A2 Bispecific antibody reactive with sialyl-Lea antigen and CD3 |
| 02/02/1994 | EP0580778A1 Convertible microemulsion formulations |
| 02/02/1994 | EP0580763A1 Compositions and methods for endothelial binding |
| 02/02/1994 | EP0580758A1 Anti-human immunodeficiency virus recombinant antibodies |
| 02/02/1994 | EP0290446B1 Vaccines for human respiratory virus |
| 02/01/1994 | US5283323 Complexing antigen to immunoglobulin; sensitivity at low dosage |